DK1309323T3 - Fremgangsmåde til behandling af angiogeneserelaterede lidelser - Google Patents

Fremgangsmåde til behandling af angiogeneserelaterede lidelser

Info

Publication number
DK1309323T3
DK1309323T3 DK01962132T DK01962132T DK1309323T3 DK 1309323 T3 DK1309323 T3 DK 1309323T3 DK 01962132 T DK01962132 T DK 01962132T DK 01962132 T DK01962132 T DK 01962132T DK 1309323 T3 DK1309323 T3 DK 1309323T3
Authority
DK
Denmark
Prior art keywords
related disorders
treating angiogenesis
angiogenesis
treating
disorders
Prior art date
Application number
DK01962132T
Other languages
English (en)
Inventor
Michael A Kapin
Daniel A Gamache
Gustav Graff
John M Yanni
David P Bingaman
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of DK1309323T3 publication Critical patent/DK1309323T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01962132T 2000-08-14 2001-08-13 Fremgangsmåde til behandling af angiogeneserelaterede lidelser DK1309323T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22513300P 2000-08-14 2000-08-14
PCT/US2001/025318 WO2002013804A2 (en) 2000-08-14 2001-08-13 Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid

Publications (1)

Publication Number Publication Date
DK1309323T3 true DK1309323T3 (da) 2007-03-19

Family

ID=22843668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01962132T DK1309323T3 (da) 2000-08-14 2001-08-13 Fremgangsmåde til behandling af angiogeneserelaterede lidelser

Country Status (19)

Country Link
US (1) US20020037929A1 (da)
EP (1) EP1309323B1 (da)
JP (2) JP5586117B2 (da)
KR (1) KR20030017653A (da)
CN (1) CN1447688A (da)
AR (1) AR030345A1 (da)
AT (1) ATE345123T1 (da)
AU (2) AU8333701A (da)
BR (1) BR0113204A (da)
CA (1) CA2417282C (da)
DE (1) DE60124560T2 (da)
DK (1) DK1309323T3 (da)
ES (1) ES2275710T3 (da)
HK (1) HK1057331A1 (da)
MX (1) MXPA03001057A (da)
PL (1) PL366220A1 (da)
PT (1) PT1309323E (da)
WO (1) WO2002013804A2 (da)
ZA (1) ZA200300782B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092669A2 (en) * 2002-05-03 2003-11-13 Alcon, Inc. Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac
BR0314364A (pt) * 2002-09-16 2005-07-19 Alcon Mfg Ltd Uso de inibidores de pde iv para tratar angiogênese
RU2352337C2 (ru) * 2002-11-12 2009-04-20 Алькон, Инк. Ингибиторы гистондеацетилазы для лечения офтальмологических неоваскулярных нарушений и заболеваний
ES2301964T3 (es) 2003-01-21 2008-07-01 Senju Pharmaceutical Co., Ltd. Preparado liquido acuoso que contiene acido 2-amino-3-(4-bromobenzoil)fenilacetico.
SI1809270T1 (sl) * 2004-11-09 2010-07-30 Alcon Inc 5,6,7-trihidroksiheptanojska kislina in analogi za zdravljenje očesnih bolezni in bolezni, povezanih s hiperproliferacijskimi in angiogenskimi odzivi
TWI358290B (en) 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations
FR2909876A1 (fr) * 2006-12-19 2008-06-20 Galderma Res & Dev S N C Snc Utilisation du nepafenac ou ses derives pour le traitement de desordres dermatologiques
WO2009073138A2 (en) * 2007-11-30 2009-06-11 Ampla Pharmaceuticals Inc. Treatment of metabolic syndrome with novel amides
US20110054031A1 (en) * 2008-02-21 2011-03-03 Ista Pharmaceuticals, Inc. Ophthalmic NSAIDS as Adjuvants
US8962686B2 (en) * 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
US9630909B2 (en) 2013-06-27 2017-04-25 Mylan Laboratories Ltd Process for the preparation of nepafenac

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH577461A5 (da) * 1975-08-13 1976-07-15 Robins Co Inc A H
ZA805476B (en) * 1979-09-26 1981-11-25 Robins Co Inc A H 2-amino-3-benzoyl-phenylacetamides and cyclic homologues
US4313949A (en) * 1979-09-26 1982-02-02 A. H. Robins Company, Inc. Method of producing an inhibitory effect on blood platelet aggregation
US4254146A (en) * 1979-10-18 1981-03-03 A. H. Robins Company, Inc. 3-Benzoyl-2-nitrophenylacetic acids, metal salts, amides and esters
IL61945A (en) * 1980-02-19 1984-09-30 Robins Co Inc A H 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
US4503073A (en) * 1981-01-07 1985-03-05 A. H. Robins Company, Incorporated 2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids
IL64724A0 (en) * 1981-02-17 1982-03-31 Robins Co Inc A H 2-amino-3-(halobenzoyl)-methylphenylacetic acids and esters and salts thereof and pharmaceutical compositions containing them
US4568695A (en) * 1983-12-07 1986-02-04 A. H. Robins Company, Incorporated 2-Amino-3-benzoyl-phenethylalcohols and intermediates therefor
US4683242A (en) * 1985-10-28 1987-07-28 A. H. Robins Company, Incorporated Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters
CA1325382C (en) * 1988-01-27 1993-12-21 Takahiro Ogawa Locally administrable therapeutic composition for inflammatory disease
US5475034A (en) * 1994-06-06 1995-12-12 Alcon Laboratories, Inc. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US5994379A (en) * 1998-02-13 1999-11-30 Merck Frosst Canada, Inc. Bisaryl COX-2 inhibiting compounds, compositions and methods of use
US6207700B1 (en) * 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
DE60016271T2 (de) * 1999-10-21 2005-12-01 Alcon Inc. Medikamentenzuführvorrichtung
US6416777B1 (en) * 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
WO2001035181A1 (en) * 1999-11-11 2001-05-17 Wireless Methods Ltd. Remote switching and actuation of electrical devices

Also Published As

Publication number Publication date
AU8333701A (en) 2002-02-25
EP1309323A2 (en) 2003-05-14
KR20030017653A (ko) 2003-03-03
AU2001283337B2 (en) 2006-06-15
CA2417282A1 (en) 2002-02-21
ES2275710T3 (es) 2007-06-16
WO2002013804A2 (en) 2002-02-21
PL366220A1 (en) 2005-01-24
JP5586117B2 (ja) 2014-09-10
DE60124560D1 (de) 2006-12-28
US20020037929A1 (en) 2002-03-28
DE60124560T2 (de) 2007-09-06
WO2002013804A3 (en) 2002-06-06
EP1309323B1 (en) 2006-11-15
MXPA03001057A (es) 2004-09-10
CA2417282C (en) 2009-12-22
PT1309323E (pt) 2007-01-31
JP2004520267A (ja) 2004-07-08
JP2012193214A (ja) 2012-10-11
CN1447688A (zh) 2003-10-08
AR030345A1 (es) 2003-08-20
ZA200300782B (en) 2004-08-27
ATE345123T1 (de) 2006-12-15
BR0113204A (pt) 2006-02-21
HK1057331A1 (en) 2004-04-02

Similar Documents

Publication Publication Date Title
DK1132569T3 (da) Fremgangsmåde til behandling af en underjordisk formation
NO20030241D0 (no) Fremgangsmåte for behandling av multiple brönnintervaller
DK1259251T3 (da) Hidtil ukendt fremgangsmåde til nedregulering af amyloid
DK1420815T3 (da) Hidtil ukendt fremgangsmåde til nedregulering af amyloid
DK2258688T3 (da) Pyridinon-derivater til behandling af aterosklerose
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
NO20011121D0 (no) FremgangsmÕte for formasjonsbehandling med deformerbare partikler
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
IS2532B (is) Aðferð til að afsalta sjó
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1997512T3 (da) Fremgangsmåder til behandling af TWEAK-relaterede tilstande
DK1324970T3 (da) Retinoider til behandling af emfysem
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK2189162T3 (da) Fremgangsmåder til behandling af cellulære proliferative forstyrrelser
DK1414492T3 (da) Fremgangsmåde til behandling af multipel myeloma
DK1353923T3 (da) Forbedret fremgangsmåde til syntese af carbapenem
DK1309323T3 (da) Fremgangsmåde til behandling af angiogeneserelaterede lidelser
DK1539200T3 (da) Fremgangsmåde til behandling af multipel sklerose
DK1314824T3 (da) Fremgangsmåde til konsolidering af jord
DK1105136T3 (da) Fremgangsmåde til behandling af okulære neovaskulære sygdomme
PT102870A (pt) Metodo de tratamento de condensados
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK3103443T3 (da) Fremgangsmåde til behandling af primær søvnforstyrrelse
NO20032156L (no) Behandling av angstforstyrrelser